Shlyakhov et al., 2004 - Google Patents
Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunityShlyakhov et al., 2004
View PDF- Document ID
- 15272155366963595975
- Author
- Shlyakhov E
- Shoenfeld Y
- Gilburd B
- Rubinstein E
- Publication year
- Publication venue
- Clinical microbiology and infection
External Links
Snippet
Three extractable Bacillus anthracis cell‐wall‐associated antigens were evaluated for potential use as skin testing agents, and as possible candidates for in‐vitro diagnosis of anthrax immunity. Anthraxin and a partially purified extractable antigen (EAP) were …
- 241000193738 Bacillus anthracis 0 title abstract description 51
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lovett et al. | Human immune responses and the natural history of Neisseria gonorrhoeae infection | |
Golshani et al. | A review of brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention | |
Chioato et al. | Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study | |
Wahdan et al. | A controlled field trial of a serogroup A meningococcal polysaccharide vaccine | |
Abkar et al. | Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection | |
Sirima et al. | Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa | |
Balseiro et al. | Development and challenges in animal tuberculosis vaccination | |
Sen et al. | Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels | |
Wolf et al. | Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice | |
Giuntini et al. | Serum bactericidal antibody responses of adults immunized with the MenB-4C vaccine against genetically diverse serogroup B meningococci | |
Tian et al. | Oral administration of Lactobacillus casei expressing flagellin A protein confers effective protection against Aeromonas veronii in common carp, Cyprinus carpio | |
Bhattacharjee et al. | Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine | |
Erskine et al. | Bovine leukemia virus infection in dairy cattle: effect on serological response to immunization against J5 Escherichia coli bacterin | |
Cherry et al. | Pediatric Q fever | |
Madetoja et al. | Efficacy of injection vaccines against Flavobacterium psychrophilum in rainbow trout, Oncorhynchus mykiss (Walbaum) | |
Hu et al. | Intradermal administration of the type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen | |
Biryukov et al. | Impact of Toll-like receptor-specific agonists on the host immune response to the Yersinia pestis plague rF1V vaccine | |
Whelan et al. | Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide | |
Ormstad et al. | The effect of endotoxin on the production of IgE, IgG1 and IgG2a antibodies against the cat allergen Fel d 1 in mice | |
Darbandi et al. | Brucellosis control methods with an emphasis on vaccination: a systematic review | |
Dijkman et al. | A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG | |
Alabdullah et al. | Evaluation of the efficacy of a cholera toxin-based staphylococcus aureus vaccine against bovine intramammary challenge | |
Bauer et al. | Humoral and cellular immune responses in sheep following administration of different doses of an inactivated phase I vaccine against Coxiella burnetii | |
Ouédraogo et al. | Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: A phase 1b randomised, controlled, double-blinded, age de-escalation trial | |
Sedgmen et al. | Alternative routes of mucosal immunization in large animals |